abstract |
The present invention relates to a compound of formula (I) or a pharmaceutically active salt thereof. The compounds of the present invention have been found to be highly potent NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD). (I) |